Tallei et al. (2025) investigated the anti-inflammatory, anticancer, and antioxidant properties of red radish microgreen extract using both in silico and in vivo approaches (with Drosophila melanogaster larvae). In silico findings showed that the extract interacted with key proteins such as MAPK1 and AKT1, which regulate pathways related to cancer, inflammation, and oxidative stress. In vivo results indicated that the extract suppressed immune-related genes and reduced ROS levels through the NFκB and JAK-STAT pathways. The gene discussed is AKT1; the disease is cancer.